Publications by authors named "Christopher Motter"

Claim this Profile
S
Synthesis and Biological Characterization of Aryl Uracil Inhibitors of Hepatitis C Virus NS5B Polymerase: Discovery of ABT-072, a trans-Stilbene Analog with Good Oral Bioavailability.
John T Randolph, A Chris Krueger, Pamela L Donner, John K Pratt, Dachun Liu, Christopher E Motter

J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A.
David A DeGoey, John T Randolph, Dachun Liu, John Pratt, Charles Hutchins, Christopher E Motter

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: synthesis and characterization of analogs with a fused 5,6-bicyclic ring motif.
A Chris Krueger, John T Randolph, David A DeGoey, Pamela L Donner, Charles A Flentge, Christopher E Motter

Bioorg Med Chem Lett· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel hepatitis C virus replicon inhibitors: synthesis and structure-activity relationships of fused pyrimidine derivatives.
A Chris Krueger, Darold L Madigan, David W Beno, David A Betebenner, Robert Carrick, Christopher E Motter

Bioorg Med Chem Lett· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors of bacterial protein synthesis: structure-activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants.
Richard F Clark, Sanyi Wang, Zhenkun Ma, Moshe Weitzberg, Christopher Motter

Bioorg Med Chem Lett· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis